Biotech & pharma that raised money in New Jersey
In the last 30 days, 2 biotech & pharma businesses in New Jersey reported raising $359M on SEC Form D. The largest was Lisata Therapeutics, Inc. ($352M).
- New raises
- 5
- Capital reported
- $374M
- Median raise
- $7.3M
Aug 3, 2026 to Oct 16, 2026
sold to investors so far
among raises with sales
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Ensho Therapeutics, Inc. | Woodcliff Lake, NJ | Health Care | $7.3M | $15.6M | |
| Lisata Therapeutics, Inc. | Basking Ridge, NJ | Health Care | $352M | $352M | |
| Grace Therapeutics, Inc. | Princeton, NJ | Health Care | $10M | $10M | |
| Bullseye Biodevices, Inc. | Hoboken, NJ | Health Care | $1.3M | $1.3M | |
| Hepion Pharmaceuticals, Inc. | Red Bank, NJ | Health Care | $3.1M | $3.1M |
Biotech & pharma nationwide · All raises in New Jersey · Filter these →